INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Results

78,999 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
HJ
Hyman JonathanChief Technology Officer
BRZEBraze, Inc.
Grant or award
A—
89.6K sh
Mar 18, 2026Mar 20, 2026
Page 1306 of 1975
← PrevNext →
traded Mar 18, 2026
+2d
SEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Grant or award
A—
18.8K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
375.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
32.3K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
21.2K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Grant or award
A—
60.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
211.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
SP
Smith Robert Paul JRChief Commercial Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
562.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
506.3K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
40.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
157.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Grant or award
A—
47.7K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
KF
Kage Kelley F.Chief Information Officer
EIGEmployers Holdings, Inc.
Tax withholding
F$6,988
179 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
MM
Mutschink John M.EVP, Chief Admin Officer
EIGEmployers Holdings, Inc.
Tax withholding
F$25K
635 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Grant or award
A—
211.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
30.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
157.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
30.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
487.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
9,167 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
157.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Grant or award
A—
176.7K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
162.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Grant or award
A—
125.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
100.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
SM
Smith Ann MarieChief Actuarial and UW Officer
EIGEmployers Holdings, Inc.
Tax withholding
F$19K
484 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Grant or award
A—
96.7K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
MW
Magnuson WilliamDirector, Chief Executive Officer
BRZEBraze, Inc.
Grant or award
A—
293.9K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
22.8K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
GE
Gessert EricaChief Financial Officer
UPWKUPWORK, INC
Option exercise
M—
9,699 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
487.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
NM
Neagle MatthewChief Operating Officer
PRCHPorch Group, Inc.
Option exercise
M—
826.6K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
126.7K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
SA
Shlimak AnnaSee Remarks
CRONCronos Group Inc.
Tax withholding
F$25K
9,767 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
440.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
18.8K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

8
WJ
White Daniel JamesDirector
AROWARROW FINANCIAL CORP
Other acquisition or disposition
J$8,448
266 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

5
HJ
Hyman JonathanChief Technology Officer
BRZEBraze, Inc.
Grant or award
A—
56.1K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

5
SW
Simi Bonny WPresident of Operations
JOBYJoby Aviation, Inc.
Grant or award
A—
100.9K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

5
BJ
Bevirt JoeBenDirector, CEO and Chief Architect
JOBYJoby Aviation, Inc.
Grant or award
A—
353.2K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence